Topics

Newron Pharmaceuticals - Xadago slows, Evenamide lags but STARS ahead

09:58 EDT 4 Oct 2019 | FinanzNachrichten

Newron Pharmaceuticals' interim results highlight that despite additional worldwide launches of Xadago, sales growth in the US and Europe remain below our expectations. For Evenamide, the company i...

Original Article: Newron Pharmaceuticals - Xadago slows, Evenamide lags but STARS ahead

NEXT ARTICLE

More From BioPortfolio on "Newron Pharmaceuticals - Xadago slows, Evenamide lags but STARS ahead"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...